Clinical Trial Update: Treatment of Impulsive Aggression (IA) in Adolescent With ADHD in Conjunction With Standard ADHD Treatment [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating treatment for impulsive aggression in adolescents with ADHD, terminated with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Supernus Pharmaceuticals product (not specified in snippet)

Snippet

Sponsor: Supernus Pharmaceuticals, Inc. | Conditions: Attention Deficit Hyperactivity Disorder | Phase 3 | Status: TERMINATED | Results posted: 2024-02-20